These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10747889)

  • 21. Synthesis, Docking Study and Biological Evaluation of Amide-Based Soluble Epoxide Hydrolase Inhibitors with Novel Secondary Pharmacophore of Pyrimidin-2-ol.
    Hejazi L; Ebadi A; Fakhar Z; Nazari M; Rezaee E; Abbas Tabatabai S
    Chem Biodivers; 2022 Nov; 19(11):e202200231. PubMed ID: 36152343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptidyl-urea based inhibitors of soluble epoxide hydrolases.
    Morisseau C; Newman JW; Tsai HJ; Baecker PA; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5439-44. PubMed ID: 16908134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudomonas aeruginosa Cif defines a distinct class of α/β epoxide hydrolases utilizing a His/Tyr ring-opening pair.
    Bahl CD; Madden DR
    Protein Pept Lett; 2012 Feb; 19(2):186-93. PubMed ID: 21933119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
    Karami L; Saboury AA; Rezaee E; Tabatabai SA
    Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular structure of an epoxide hydrolase from Trichoderma reesei in complex with urea or amide-based inhibitors.
    de Oliveira GS; Adriani PP; Ribeiro JA; Morisseau C; Hammock BD; Dias MVB; Chambergo FS
    Int J Biol Macromol; 2019 May; 129():653-658. PubMed ID: 30771398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.
    Eldrup AB; Soleymanzadeh F; Farrow NA; Kukulka A; De Lombaert S
    Bioorg Med Chem Lett; 2010 Jan; 20(2):571-5. PubMed ID: 19969453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active site of epoxide hydrolases revisited: a noncanonical residue in potato StEH1 promotes both formation and breakdown of the alkylenzyme intermediate.
    Thomaeus A; Carlsson J; Aqvist J; Widersten M
    Biochemistry; 2007 Mar; 46(9):2466-79. PubMed ID: 17284015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
    Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
    Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capturing LTA
    Stsiapanava A; Samuelsson B; Haeggström JZ
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9689-9694. PubMed ID: 28827365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The x-ray structure of epoxide hydrolase from Agrobacterium radiobacter AD1. An enzyme to detoxify harmful epoxides.
    Nardini M; Ridder IS; Rozeboom HJ; Kalk KH; Rink R; Janssen DB; Dijkstra BW
    J Biol Chem; 1999 May; 274(21):14579-86. PubMed ID: 10329649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soybean epoxide hydrolase: identification of the catalytic residues and probing of the reaction mechanism with secondary kinetic isotope effects.
    Blée E; Summerer S; Flenet M; Rogniaux H; Van Dorsselaer A; Schuber F
    J Biol Chem; 2005 Feb; 280(8):6479-87. PubMed ID: 15596432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
    Jones PD; Tsai HJ; Do ZN; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5212-6. PubMed ID: 16870439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into the reaction mechanism of soluble epoxide hydrolase from theoretical active site mutants.
    Hopmann KH; Himo F
    J Phys Chem B; 2006 Oct; 110(42):21299-310. PubMed ID: 17048959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.
    Takai K; Chiyo N; Nakajima T; Nariai T; Ishikawa C; Nakatani S; Ikeno A; Yamamoto S; Sone T
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1705-1708. PubMed ID: 25800114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors:
    Codony S; Pujol E; Pizarro J; Feixas F; Valverde E; Loza MI; Brea JM; Saez E; Oyarzabal J; Pineda-Lucena A; Pérez B; Pérez C; Rodríguez-Franco MI; Leiva R; Osuna S; Morisseau C; Hammock BD; Vázquez-Carrera M; Vázquez S
    J Med Chem; 2020 Sep; 63(17):9237-9257. PubMed ID: 32787085
    [No Abstract]   [Full Text] [Related]  

  • 36. Catalytic mechanism of limonene epoxide hydrolase, a theoretical study.
    Hopmann KH; Hallberg BM; Himo F
    J Am Chem Soc; 2005 Oct; 127(41):14339-47. PubMed ID: 16218628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Removal of distal protein-water hydrogen bonds in a plant epoxide hydrolase increases catalytic turnover but decreases thermostability.
    Thomaeus A; Naworyta A; Mowbray SL; Widersten M
    Protein Sci; 2008 Jul; 17(7):1275-84. PubMed ID: 18515642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight-binding inhibitors.
    Thunnissen MM; Andersson B; Samuelsson B; Wong CH; Haeggström J
    FASEB J; 2002 Oct; 16(12):1648-50. PubMed ID: 12207002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.
    Du F; Sun W; Morisseau C; Hammock BD; Bao X; Liu Q; Wang C; Zhang T; Yang H; Zhou J; Xiao W; Liu Z; Chen G
    Eur J Med Chem; 2021 Nov; 223():113678. PubMed ID: 34218083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site.
    Arand M; Hallberg BM; Zou J; Bergfors T; Oesch F; van der Werf MJ; de Bont JA; Jones TA; Mowbray SL
    EMBO J; 2003 Jun; 22(11):2583-92. PubMed ID: 12773375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.